Cormorant Asset Management, LP, Director Other at Pyxis Oncology, Inc. (PYXS), bought 1,118,854 shares at $16.00 ($7.2M) on 2021-10-13, disclosed to the SEC on 2021-10-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 668,854 | $0 | 0.0% |
| 2 | $16.00 | 450,000 | $7.2M | 100.0% |
| Total | $6.44 avg | 1,118,854 | $7.2M | 100% |
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |